Major histocompatibility complex class II-transfected tumor cells present peptides from endogenously encoded antigen in vitro and in vivo

As tumor immunotherapies are developed, emphasis is being placed on the activation of tumor-specific T-cells for treating recurring disease. Most immunotherapeutic strategies have concentrated on the activation of tumor-specific CD8...